Could a simple questionnaire transform diabetes consultations?

NCT ID NCT07767331

NEW Recruiting now Disease control Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial tests whether using a diabetes-specific questionnaire during annual check-ups can improve the quality of care for people with type 2 diabetes. About 2,000 adults with type 2 diabetes from 30 general practices in Denmark will take part. Half of the practices will use the questionnaire to guide consultations, while the other half will follow usual care. The study will measure patient-perceived quality of care and explore how the questionnaire affects the consultation experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Use of a diabetes-specific patient-reported outcomes (PRO) questionnaire in general practice consultations
What this could lead to: If effective, this approach could make diabetes consultations more personalized and patient-centered, potentially improving care quality and outcomes for people with type 2 diabetes.
What could go wrong: This is a pragmatic trial in general practice, and results may vary across settings. The primary outcome is patient-perceived quality of care, which may not directly translate to clinical improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Steno Diabetes Center Aarhus
RECRUITING

Aarhus, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.